Peter Eriksson

Kontakt

peter.n.eriksson@umu.se

090-785 00 00

Verksam vid

Anknuten som forskare till Institutionen för folkhälsa och klinisk medicin

Byggnad 1A, plan 4, målpunkt B41, Norrlands universitetssjukhus Umeå universitet, 901 85 Umeå

Publikationer Publikationer

Bivalirudin versus heparin monotherapy in non-ST-segment elevation myocardial infarction

European Heart Journal: Acute Cardiovascular Care, Sage Publications 2019, Vol. 8, (6) : 492-501

Erlinge, David; Koul, Sasha; Omerovic, Elmir; et al.

Radial versus femoral access in patients with acute coronary syndrome undergoing invasive management: A prespecified subgroup analysis from VALIDATE-SWEDEHEART

European Heart Journal: Acute Cardiovascular Care, Sage Publications 2019, Vol. 8, (6) : 510-519

Volz, Sebastian; Angeras, Oskar; Koul, Sasha; et al.

Bivalirudin versus heparin monotherapy in myocardial infarction

New England Journal of Medicine, Massachusetts Medical Society 2017, Vol. 377, (12) : 1132-1142

Erlinge, D.; Omerovic, E.; Frobert, O.; et al.

Bivalirudin versus heparin in non-ST and ST-segment elevation myocardial infarction-a registry-based randomized clinical trial in the SWEDEHEART registry (the VALIDATE-SWEDEHEART trial)

American Heart Journal, Vol. 175 : 36-46

Erlinge, David; Koul, Sasha; Eriksson, Peter; et al.

Treatment Patterns and Outcomes in Patients Undergoing Percutaneous Coronary Intervention Treated With Prasugrel or Clopidogrel (from the Swedish Coronary Angiography and Angioplasty Registry [SCAAR])

American Journal of Cardiology, Vol. 113, (1) : 64-69

Damman, Peter; Varenhorst, Christoph; Koul, Sasha; et al.

Population Trends in Percutaneous Coronary Intervention 20-Year Results From the SCAAR (Swedish Coronary Angiography and Angioplasty Registry)

Journal of the American College of Cardiology, Vol. 61, (12) : 1222-1230

Fokkema, Marieke L.; James, Stefan K.; Albertsson, Per; et al.

Pure coronary ectasia differs from atherosclerosis: morphological and risk factors analysis

International Journal of Cardiology, Vol. 155, (2) : 321-323

Boles, Usama; Zhao, Ying; David, Santhosh; et al.

Coronary artery ectasia: remains a clinical dilemma.

Coronary Artery Disease, Lippincott Williams & Wilkins 2010, Vol. 21, (5) : 318-320

Boles, Usama; Eriksson, Peter; Zhao, Ying; et al.

Risks associated with drug-eluting stents.

Lancet, Vol. 369, (9575) : 1785-1786

Carlsson, Jörg; Eriksson, Peter

[Thrombolysis-treated ST-segment elevation myocardial infarction. Clopidogrel administration should be a standard]

Läkartidningen, Vol. 103, (1-2) : 21-

Eriksson, Peter

[Aggressive or conservative strategy in unstable coronary disease. Is the scrutiny of the investigating experts by the three professors unbiased?]

Läkartidningen, Vol. 103, (30-31) : 2240-1; discussion 2241

Eriksson, Peter; Näslund, Ulf

Cost-effectiveness of clopidogrel plus aspirin versus aspirin alone.

Annals of internal medicine, Vol. 143, (6) : 464; author reply 464-5

Eriksson, Peter

Economic effects of extended clopidogrel therapy--a word of caution.

Journal of the American College of Cardiology, Vol. 46, (7) : 1376; author reply 1376-7

Eriksson, Peter

Perkutana koronarinterventioner. Sämre resultat och fler allvarliga komplikationer på enheter med små volymer.

Läkartidningen, Vol. 102 : 111-

Eriksson, Peter

Long-term clopidogrel following PCI: marginal antithrombotic effects are offset by increased bleeding risks

European Heart Journal, Vol. 25, (23) : 2170-1

Eriksson, Peter

Long-term clopidogrel therapy in the drug eluting stent era: beyond CREDO and CURE-PCI: Reply

European Heart Journal, Vol. 25, (15) : 1364-5

Eriksson, Peter

Cardiac involvement in familial amyloidosis with polyneuropathy

Umeå University medical dissertations, 118

Eriksson, Peter

Visa publikationer i DiVA